AiVita Biomedical, Inc. — Form D/A
AiVita Biomedical, Inc. of IRVINE, CA, a company, filed a Form D amendment with the SEC on 2018-03-15. The offering totals $5.5M, of which $5.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-03-15
- Form: D/A
- Accession: 0001676258-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.5M
- Amount sold: $5.5M
- Investors: 20
- Date of first sale: 2016-05-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-264429
Issuer
- Name: AiVita Biomedical, Inc.
- CIK: 0001676258
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 18301 VON KARMAN AVE., SUITE 130, IRVINE, CA, 92612
- Phone: 949-872-2555
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| CHRIS FIBIGER | Director | TACOMA, WA |
| Scott Burell | Executive Officer | BRAINTREE, MA |
| Alexander Suh | Director | Irvine, CA |
| Hans Keirstead | Director | Irvine, CA |
| Hans Keirstead | Executive Officer | Irvine, CA |
| Matthew Katz | Director | San Francisco, CA |
| Ungbae Lee | Director | Irvine, CA |
| Paul Jenkinson | Director | Irvine, CA |
| Philippe Schaison | Director | Newport Beach, CA |
| Gabriel S Nistor | Executive Officer | Irvine, CA |
| Alexander B Suh | Director | Irvine, CA |
| Hans S Keirstead | Director | Irvine, CA |
| Hans S Keirstead | Executive Officer | Irvine, CA |
| Susan B Bloomfield | Director | Irvine, CA |
| Ungbae B Lee | Director | Irvine, CA |
| Ed B Inal | Executive Officer | Irvine, CA |
Other filings by this issuer (4)
More